DALLAS, June 16, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring AtriCure Inc. (Nasdaq:ATRC). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at: www.microstockprofit.com/lp/ATRC
AtriCure Inc. (ATRC) is a medical device company engaged in developing, manufacturing and selling cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart tissue. The Company has three primary product lines. Its primary product line, which accounts for a majority of its revenues, is Isolator Synergy Bipolar Ablation Clamp System (Isolator system) and related radiofrequency ablation devices. It also offers a cryoablation product line, which features reusable and disposable cryoablation devices. During the year ended December 31, 2009, the Company initiated a European launch of its AtriClip Gillinov-Cosgrove Left Atrial Appendage System (AtriClip system), which is designed to exclude the left atrial appendage.
Message Board Search for ATRC: http://www.boardcentral.com/boards/ATRC
In the report, the analyst notes:
"Revenues for the first quarter of 2010 were $14.0 million, a $0.3 million increase when compared to first quarter 2009 revenues of $13.7 million. Revenues from domestic open heart products for the first quarter of 2010 increased to $7.2 million from $7.1 million. Revenues from domestic minimally invasive products declined from $4.3 million for the first quarter of 2009 to $3.9 million for the first quarter 2010.
"ATRC recently announced that it received clearance from the FDA for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion system. The AtriClip system is designed to safely and effectively exclude the left atrial appendage. Initial launch in the United States is anticipated to begin later this month with full commercial release planned during the third quarter of 2010."
To read the entire report visit: www.microstockprofit.com/lp/ATRC
See what investors are saying about ATRC at penny stock forum
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.